Biochips

Summary

Significant dimensions of the vast parallel studies afforded by biochips have created a holistic means of viewing biological systems. In addition to the combination of various sciences, space, time and expense are all key factors in the future development of biochips. Modern day chips can contain a human genome comprising of 30,000 to 100,000 genes.

The biochip industry is in the early stages of growth and hence, not only promises potential but also is susceptible to vagaries of market forces. Competition, patent disputes, knowledge constraints (in terms of skilled employees, technical know-how) and financial strength might be a few impediments for firms engaged in this industry. A promising market arises from three factors - an aging population, third party reimbursement and a growing number of individuals suffering from common chronic diseases. Biochips would certainly evolve in terms of physical, technical characteristics, and with focus on miniaturization of assays, they would turn smaller and more powerful with each generation. The industry is characterized by both intense rivalry and equally well-developed web of alliances.

These and other market data and trends are presented in ""Biochips: A Global Update of Market Trends & Opportunities"" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

• 1.Methodology
  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level
• 2.Industry Overview
  • Promising Biochips Promote Biological Research
  • Market Scenario across Products and Regions
  • DNA Chips Lead The Application Front
  • Probable Industry Directions
  • Biochip Technology Boosts Personalised Medicine
  • Biochip Technology Spreads beyond Pharma Industry
  • Protein Chips to Shape The Future
  • Proteomics "chip" into Biochip Technology
  • towards Increasing Minaturization
  • European Advancements Set Diagnostic Procedures
  • Competitive Scenario
  • Major Participants
  • Roche and Affymetrix Taste Success in The Diagnostics Market
  • Growing Partnerships between Pharma and Biotech Companies
  • Tech Giants Join The Biochip Fray
• 3.Product Facts
  • A. DNA Chips
  • B. Protein Chips
  • C. Lab Chips
• 4.Applications of Biochips
  • Biochip Uses
  • Biochips and Pharmaceutical Investigation
  • Biochips and Medical Diagnostics
  • Advantages of Biosensor Chip Technology
  • Biochips and Forensics
  • Biochips and Transplantation Screening
  • Biochips and Identity Testing
  • Biochips and Water and Environmental Testing
  • Food Industry
• 5.Trends
  • Industry Characteristics
  • New Products and Players to Drive Market
  • Key Forces Boosting The Industry
  • Industry Structure
  • Industry Challenges
  • Price Dearness Pauses Biochips Growth
  • Current Approaches to Biochips
  • The Business of Biochips
  • Technological Trends
  • Sensitivity
  • Microfabrication
  • Density
  • Integrated Chips
  • Patent Trends
  • Patent Applications
• 6.next Generation Technology
  • Microfluidics Using CD-Rom Technology
• 7.Corporate Developments
  • Affymetrix Acquires USB
  • Illumina Announces Partnership with Genpathway for Chip Sequencing Services
  • Affymetrix and Avesthagen Enter into An Agreement
  • Roche Nimblegen and Affymetrix Announce Expansion of License Agreement
  • Gatc Biotech Establishes New Subsidiary
  • Affymetrix Introduces Complete Cytogenetic Solution
  • Sigma Launches Chip Kit
  • US and Czech Scientists to Develop Biochips for Detecting Cancer
  • Roche Takes over Nimblegen
  • Gentel Biosciences Acquires Protein Chip Platform Assets of Gsk
  • Advanced Liquid Logic Acquires Nanolytics
  • Applied Microarrays Acquires Select Ge Healthcare's Assets
  • Affymetrix and Partners Healthcare Extend Collaboration
  • Agencourt, Nugen and Affymetrix Clinical Services Collaborate
  • Affymetrix Inks Licensing Agreement with Empire Genomics
  • Caliper Enters into A Licensing Agreement with Monogram Biosciences
  • Affymetrix and Ipsogen Sign Agreement
  • Biomrieux and Nugen Enter into Supply and Cross-License Agreement
  • Vwr and Capitalbio Enter into A Distribution Agreement
  • Ucl Subsidiary and Roche Diagnostics Ink Licensing Deal
  • Affymetrix Establishes The European Cytogenetic Research Initiative.
  • Roche Introduces Gene Expression Services and Arrays
  • Affymetrix Unveils Affymetrix Genechip Command Console Software
  • Affymetrix Introduces Genechip Mouse and Rat Gene 1.0 St Arrays
  • Affymetrix Unveils Genome-Wide Human Snp Array 6.0
  • Caliper Life Sciences Launches High Throughput Rna Assay
  • Applied Biosystems Unveils DNA Tools
  • Febit Launches Geniom Rt Analyzer
  • Austrian Research Center Develops New Biochip Surface
  • Researchers Develop Biochips to Eliminate Animal Testing
• 8.Major Players
  • Affymetrix (US)
  • Applied Biosystems Group (US)
  • Biomerieux (France)
  • Bio-Rad Laboratories, Inc. (US)
  • Caliper Life Sciences, Inc. (US)
  • Cepheid Inc. (US)
  • Ge Healthcare Ltd (UK)
  • Takara Bio, Inc. (Japan)
  • Zyomyx (US)
• 9.Market Analytics
• 10.The United States
  • Biochips Market Overview
  • Time Saving Biochips - All Set to Grow
  • Multiple Applications of Biochips Drive Sales
  • Biochip Market Faces Challenges
• 11.Canada
• 12.Japan
  • DNA Chip Based on Printing Technology
  • DNA Chips to Reveal Links among Genes
  • A Leading Japanese Biochip Player - Takara Shuzo
  • Ican Technology for Large-Scale Production of DNA Fragments
• 13.Europe
  • A.France
  • B.Germany
  • C.The United Kingdom
  • D.Rest of Europe
• 14.Rest of World
  • China
  • Basic Environment and Commercial Development
  • Biochip Research
  • Status of Biochip Industry in China
  • Taiwan
  • Taiwan Pursues Promise of Biochip Sector
  • International Advantage Sought60table 1: Market Shares of Biochips Patent Applications in The World -
• List of Tables
  • Table 2: Global Biochips Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 3: Percentage Breakdown of Global Biochips Market by Region for The Years 2008 &
  • Table 4: Global DNA Chips Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 5: Percentage Breakdown of Global DNA Chips Market by Region for The Years 2008 &
  • Table 6: Global Protein Chips Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 7: Percentage Breakdown of Global Protein Chips Market by Region for The Years 2008 &
  • Table 8: Global Lab Chips Market by Region for The Period 2007-2015 (Sales in US$ Million)
  • Table 9: Percentage Breakdown of Global Lab Chips Market by Region for The Years 2008 &
  • Table 10: Biochips Market by Segment in The US: 2007-2015 (Sales in US$ Million)
  • Table 11: Percentage Breakdown of Biochips Market by Segment in The US for The Years 2008 &
  • Table 12: Biochips Market by Segment in Canada: 2007-2015 (Sales in US$ Million)
  • Table 13: Percentage Breakdown of Biochips Market by Segment in Canada for The Years 2008 &
  • Table 14: Biochips Market by Segment in Japan: 2007-2015 (Sales in US$ Million)
  • Table 15: Percentage Breakdown of Biochips Market by Segment in Japan for The Years 2008 &
  • Table 16: Biochips Market by Region in Europe: 2007-2015 (Sales in US$ Million)
  • Table 17: Percentage Breakdown of Biochips Market by Region in Europe for The Years 2008 &
  • Table 18: Biochips Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
  • Table 19: Percentage Breakdown of Biochips Market by Segment in Europe for The Years 2008 &
  • Table 20: Biochips Market by Segment in France: 2007-2015 (Sales in US$ Million)
  • Table 21: Percentage Breakdown of Biochips Market by Segment in France for The Years 2008 &
  • Table 22: Biochips Market by Segment in Germany: 2007-2015 (Sales in US$ Million)
  • Table 23: Percentage Breakdown of Biochips Market by Segment in Germany for The Years 2008 &
  • Table 24: Biochips Market by Segment in The UK: 2007-2015 (Sales in US$ Million)
  • Table 25: Percentage Breakdown of Biochips Market by Segment in The UK for The Years 2008 &
  • Table 26: Biochips Market by Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
  • Table 27: Percentage Breakdown of Biochips Market by Segment in Rest of Europe for The Years 2008 &
  • Table 28: Biochips Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
  • Table 29: Percentage Breakdown of Biochips Market by Segment in Rest of World for The Years 2008 &
• Companies Profiled